Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)

NCT00424268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

743

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Roflumilast
DRUG: Placebo

Sponsor

AstraZeneca